Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Accordi

CAR- T Cell Therapy Market Overview, Drivers and Impact of Coronavirus (COVID-19) Pandemic

CAR T-cell treatment with chimeric antigen receptors (CAR) is a method of obtaining immune cells known as T cells. CAR T-cell therapy is used to treat lymphomas, leukemias, and multiple myeloma, among other diseases. Many clinical trials for CAR T-cell treatments have been done around the world in order to expand the therapy options for cancer. In 2010, the National Cancer Institute's research team published the first study on CAR T-cell therapy, a new type of cancer treatment.

Global Car T Cell Therapy Market – Impact of Coronavirus (COVID-19) Pandemic

As a result of the COVID–19 outbreak and a reduction of global research effort, many firms around the world have seen their operations and financial performance deteriorate. The closing of academic and scientific institutes, as well as testing facilities, has had a significant detrimental impact. As a result, the CAR-T cell therapy market trials have been pushed back.

CAR- T Cell Therapy Market
CAR-T Cell Therapy Market


COVID-19 is a serious hazard to the health of susceptible patients, such as those who are immunocompromised. Due to their severely immunocompromised state, induced by past lymphodepleting immunochemotherapy and CAR-T-cell therapy-related side effects such as B-cell depletion, hypogammaglobulinemia, and cytopenias, CAR T-cell therapy recipients are at a significant risk of poor COVID-19.

 

Car T Cell Therapy Market Drivers

Because of the rising prevalence of cancer patients around the world, the CAR T treatment industry is predicted to rise. Because of the amazing responses it has elicited in patients, this treatment has piqued the interest of researchers and the general public. In 2017, the Food and Drug Administration (FDA) approved two CAR T therapies, one for children with ALL and the other for adults with advanced lymphomas.

The use of chimeric antigen receptors for cancer treatment has seen steady increase in the biotechnology and life science industries. Patient assistance programmes (PAPs), increased government cancer awareness activities, rising cancer prevalence worldwide, and strong R&D initiatives from leading businesses are all propelling the CAR-T cell therapy market forward. Producers have begun investing in the manufacturing of cell-based therapy in response to the increased demand for it.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Global Disposable Face Mask Market Share

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic